CDKN1C and pancreatic neoplasm: For instance, LINC-PINT inhibited melanoma proliferation and migration by binding to EZH2 [46], and lncRNA-BLACAT1 promoted pancreatic cancer cell proliferation and migration by suppressing CDKN1C expression via EZH2-induced H3K27me3 [47].